In this edition, digital imaging and AI advance investigation of systemic disease through the retina; handheld retinal imaging devices may have utility in screening; Xipere launches in the US; and more. Read the full coverage here: <a href= "https://www.healio.com/news/ophthalmology/20220317/digital-imaging-ai-advance-investigation-of-systemic-disease-through-the-retina"> Digital imaging, AI advance investigation of systemic disease through the retina</a> <a href= "https://www.healio.com/news/ophthalmology/20220324/no-additional-visual-benefit-seen-with-nesvacumabaflibercept-combination-in-dme"> No additional visual benefit seen with nesvacumab-aflibercept combination in DME</a> <a href= "https://www.healio.com/news/ophthalmology/20220325/soft-drusen-subretinal-drusenoid-deposits-may-be-separate-diseases-leading-to-amd"> Soft drusen, subretinal drusenoid deposits may be separate diseases leading to AMD</a> <a href= "https://www.healio.com/news/ophthalmology/20220329/xipere-launches-in-us"> Xipere launches in US</a> <a href= "https://www.healio.com/news/ophthalmology/20220330/handheld-retinal-imaging-devices-may-have-utility-in-screening"> Handheld retinal imaging devices may have utility in screening</a> References: Healio Interviews <a href= "https://journals.lww.com/retinajournal/Abstract/9000/Intravitreal_Nesvacumab__Anti_Angiopoietin_2__Plus.95242.aspx"> Brown DM, et al. Retina. 2022;doi:10.1097/IAE.0000000000003441.</a> <a href= "https://journals.lww.com/retinajournal/Abstract/9000/Subretinal_Drusenoid_Deposits_and_Soft_Drusen__Are.95245.aspx"> Thomson RJ, et al. Retina. 2022;doi:10.1097/IAE.0000000000003460.</a> <a href= "https://www.bausch.com/our-company/recent-news/artmid/11336/articleid/687/03282022"> Press Release</a> <a href= "https://www.ophthalmologyretina.org/article/S2468-6530(22)00089-6/fulltext"> Salongcay RP, et al. Ophthalmol Retina. 2022;doi:10.1016/j.oret.2022.03.002</a>

Neurology Edition: Top Headlines for Week of April 18, 2022

The latest news you need, when you need it.